Quantcast

Posts related to ‘Pharmaceuticals’

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Posted: October 19, 2011 at 10:18 am

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public.  So what about when a company decides to unlock shareholder value by ...
Read Full Story »

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Posted: October 12, 2011 at 2:10 pm

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription ...
Read Full Story »

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Posted: August 29, 2011 at 12:39 pm

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type ...
Read Full Story »

Picking Apart the Dendreon Implosion (DNDN)

Posted: August 4, 2011 at 7:59 am

Dendreon Corporation (NASDAQ: DNDN) was supposed to be the Holy Grail when it comes to investing in a treatment for prostate cancer.  The limited life-extension versus a high cost for ...
Read Full Story »

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Posted: August 2, 2011 at 10:01 am

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning.  The results of both drug behemoths are largely in line with ...
Read Full Story »

National Employee Morale Day At Merck (MRK)

Posted: July 30, 2011 at 8:14 am

Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000 people. These employees can leave with the knowledge that they ...
Read Full Story »

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Posted: June 16, 2011 at 8:10 am

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition.  ...
Read Full Story »

M&A Watch: Biotech Deals Keep Rolling, Who Is The Next Buyout Target? (TEVA, VRX, CEPH, CRA, ALXN, DNDN, CBST, HGSI, UTHR, CADX, AMAG, SGMO)

Posted: May 2, 2011 at 7:46 pm

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ: CEPH) in a $6.8 billion deal.  The merger will give ...
Read Full Story »

GNC Tries Tame Re-IPO (GNC)

Posted: April 1, 2011 at 10:32 am

GNC Holdings Inc. (NYSE: GNC) is public again.  The vitamin and nutrients retailer sold 22.5 million shares at a price of $16.00 per share.  This was in the middle of ...
Read Full Story »

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

Posted: March 28, 2011 at 10:01 am

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma.  The approval is a win for ...
Read Full Story »

The 10 Companies That Will Save The American Economy

Posted: March 25, 2011 at 4:31 am

America lost its lead as the world’s top manufacturer to China. That is in part the basis of the argument that China’s Gross Domestic Product will pass America’s sometime before ...
Read Full Story »

Daily Dividend: Will Amgen Finally Start Paying Shareholders? (AMGN, PFE, MRK)

Posted: March 24, 2011 at 11:10 am

It is time for "The Daily Dividend" and we have an interesting call ahead.  How long has it been that Amgen Inc. (NASDAQ: AMGN) has been touted as a "Should Be" ...
Read Full Story »

Companies That Can’t Keep Their Products On The Shelves

Posted: March 21, 2011 at 5:13 am

It is not unusual for companies with highly successful products to run out of inventory. Oftentimes, companies are forced to scramble at the last minute to meet an unexpected upsurge ...
Read Full Story »

GrowOp: The Hydroponic IPO For Medical Marijuana

Posted: February 18, 2011 at 4:40 am

Medical marijuana is easily one of the most controversial businesses in America today.  It is also one super-fast growth industry.  24/7 Wall St. is always on the lookout for issues ...
Read Full Story »

Ten Companies Running Out Of American Customers

Posted: February 1, 2011 at 5:58 am

Companies locked in a struggle to remain viable and maintain their profits and sales sometimes begin to run out of customers. This happened to GM (NYSE: GM), which had a ...
Read Full Story »